- Home
- ALAR vs COEP Comparison
ALAR vs COEP Comparison
Compare ALAR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- COEP
- Stock Information
- Founded
- ALAR 2013
- COEP 2017
- Country
- ALAR Israel
- COEP United States
- Employees
- ALAR N/A
- COEP N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALAR Technology
- COEP Health Care
- Exchange
- ALAR Nasdaq
- COEP Nasdaq
- Market Cap
- ALAR 41.3M
- COEP 39.0M
- IPO Year
- ALAR 2018
- COEP N/A
- Fundamental
- Price
- ALAR $6.82
- COEP $9.50
- Analyst Decision
- ALAR Strong Buy
- COEP
- Analyst Count
- ALAR 1
- COEP 0
- Target Price
- ALAR $11.00
- COEP N/A
- AVG Volume (30 Days)
- ALAR 86.4K
- COEP 103.6K
- Earning Date
- ALAR 05-29-2025
- COEP 05-20-2025
- Dividend Yield
- ALAR N/A
- COEP N/A
- EPS Growth
- ALAR N/A
- COEP N/A
- EPS
- ALAR 0.08
- COEP N/A
- Revenue
- ALAR $31,824,000.00
- COEP N/A
- Revenue This Year
- ALAR N/A
- COEP N/A
- Revenue Next Year
- ALAR $12.28
- COEP N/A
- P/E Ratio
- ALAR $8.53
- COEP N/A
- Revenue Growth
- ALAR 20.00
- COEP N/A
- 52 Week Low
- ALAR $5.45
- COEP $2.31
- 52 Week High
- ALAR $46.69
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- ALAR 48.34
- COEP 51.27
- Support Level
- ALAR $6.31
- COEP $7.81
- Resistance Level
- ALAR $7.15
- COEP $11.17
- Average True Range (ATR)
- ALAR 0.44
- COEP 1.39
- MACD
- ALAR -0.02
- COEP -0.05
- Stochastic Oscillator
- ALAR 36.69
- COEP 51.92
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.